Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.22 USD
0.00 (1.91%)
Updated Oct 16, 2024 03:59 PM ET
After-Market: $0.22 0.00 (-1.70%) 6:14 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 28% (71 out of 250)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.50 | 1.55 | 9.99 |
Current Quarter Estimate | -0.21 | 0.07 | 63.00 |
Year Ago Quarter Estimate | -0.33 | 0.12 | 52.25 |
Next Quarter Estimate | -0.09 | -2.02 | 66.00 |
Next Year Estimate | -0.35 | 11.91 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 47.73 | 17.60 | 15.67 |
Next Year | 49.28 | 16.90 | 11.34 |
Last 5 Years | NA | 5.00 | 8.10 |
Next 5 Years | NA | 20.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.52 |
Price/Book (MRQ) | NA | 1.54 |
Price/Cash Flow (MRFY) | NA | 8.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -203.98% |
Return on Equity (TTM) | -449.60% | -81.98% |
Debt to Equity (MRQ) | NA | 0.64 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.